Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced.

The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units.

Jeffrey Sosman, M.D., professor of Medicine, Ingram Chair for Cancer Research and director of the Vanderbilt Melanoma Program, was named one of the Hottest Scientific Researchers of the last year by Thomas Reuters Science Watch.

Recent scientific findings have raised the fear that young athletes may fare worse after sustaining a sports-related concussion than older athletes.

Stacy Stark, D.O., has been named medical director of Pediatric Rehabilitation Services at the Monroe Carell Jr. Children’s Hospital at Vanderbilt. She is also assistant professor of Physical Medicine and Rehabilitation (PM&R).

We’re on a potential collision course, said last week’s Flexner Discovery Lecturer, between the delivery of good medical care and the possibilities offered by genome medicine.

Award-winning New York Times science writer and columnist Carl Zimmer will deliver the next Flexner Discovery Lecture on Thursday, Oct. 3, on setting science “right” when it goes “wrong.”